Examples of using Lipoatrophy in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
Lipodystrophy lipoatrophy/ lipomatosis.
The injection site should be alternated to prevent lipoatrophy.
eczema, lipoatrophy, pruritus, rash.
arms and face lipoatrophy.
The incidence and severity of lipoatrophy are related to cumulative exposure.
Common: lipoatrophy,* lipodystrophy uncommon:
Fatty tissue under the skin may shrink(lipoatrophy) or get thicker lipohypertrophy.
Lipoatrophy was commonly reported in patients treated with stavudine in combination with other antiretrovirals see section 4.4.
Lipodystrophy(including lipohypertrophy, lipoatrophy) may occur at the injection site.
Lipoatrophy: Treatment with zidovudine has been associated with loss of subcutaneous fat,
Lipodystrophy(including lipohypertrophy, lipoatrophy) may occur at the injection site.
Lipoatrophy: stavudine has been shown to cause loss of subcutaneous fat,
eczema, lipoatrophy, pruritus, rash.
The incidence and severity of lipoatrophy are cumulative over time with stavudine-containing regimens.
Protease Inhibitors and lipoatrophy and NRTIs has been hypothesised.
Injecting INCRELEX can cause local lipoatrophy(loss of fat),
Fatty tissue under the skin may shrink(lipoatrophy) or get thicker lipohypertrophy.
A connection between visceral lipomatosis and PIs and lipoatrophy and Nucleoside Reverse Transcriptase Inhibitors(NRTIs) has been hypothesised.
fatty tissue under the skin at this site may shrink(lipoatrophy) or thicken lipohypertrophy.
Lipoatrophy was observed in a long-term follow-up study of stavudine in combination with lamivudine
fatty tissue under the skin at this site may shrink(lipoatrophy) or thicken lipohypertrophy.
Lipoatrophy: on the basis of mitochondrial toxicity stavudine has been shown to cause loss of subcutaneous fat,
A connection between visceral lipomatosis and protease inhibitors and lipoatrophy and nucleoside reverse transcriptase inhibitors has been hypothesised.
the site of injection must be varied to prevent lipoatrophy.
protease inhibitors and lipoatrophy and nucleoside reverse transcriptase inhibitors has been hypothesised.
should be made and an alternative antiretroviral should be carefully considered see Lactic acidosis, Lipoatrophy, and Peripheral neuropathy below and section 4.8.
Given the potential risks of using Zerit including lipoatrophy, a benefit-risk assessment for each patient should be made and an alternative antiretroviral carefully considered.
Three side effects are possibly related to the medicine's toxic effect on mitochondria(the energy- producing components within cells): lipoatrophy, lactic acidosis(a build-up of lactic acid in the body)
hyperhidrosis, lipoatrophy, lipodystrophy acquired,
A connection between visceral lipomatosis and protease inhibitors(PIs), and lipoatrophy and nucleoside reverse transcriptase inhibitors(NRTIs).
